Showing results (161-170 of 274) with videos related to

Sort By:
Pageof 28
Journal of the National Cancer Institute|June 25, 2014
TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trialFrancesco Sclafani, David Gonzalez, David Cunningham, et al.
Expert Review of Anticancer Therapy|March 19, 2020
Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019David K Lau, Matthew Burge, Amitesh Roy, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 25, 2019
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancerIan Chau, Dung T Le, Patrick A Ott, et al.
The Oncologist|June 2, 2018
Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF)Hendrik-Tobias Arkenau, Juan Martin-Liberal, Emiliano Calvo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 4, 2019
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancerIan Chau, Dung T Le, Patrick A Ott, et al.
British Journal of Haematology|March 22, 2003
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphomaIan Chau, Mark Harries, David Cunningham, et al.
Cancers|October 17, 2019
Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer CenterAlexandros Georgiou, Shelize Khakoo, Penelope Edwards, et al.
Oncotarget|February 11, 2016
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trialKhurum Khan, David Cunningham, Clare Peckitt, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2020
Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary positionAntonin Levy, Anna D Wagner, Cyrus Chargari, et al.
International Journal of Cancer|June 15, 2019
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patientsFrancesco Sclafani, Sanna Hulkki Wilson, David Cunningham, et al.
Pageof 28